How common is prostate cancer?

Posted by  | Research

Prostate cancer is extremely common in the U.S. “It’s the most common life-threatening cancer in men, responsible for 26,000 deaths per year,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. But there are a lot of prostate cancers that are not life-threatening, he says. “In autopsies(...)

Natural Remedies Being Studied for Breast Cancer

Natural Remedies Being Studied for Breast Cancer

Posted by  | treatment

In your Facebook feed, in conversations with friends, in a magazine article—the talk about natural remedies for preventing and treating breast cancer seems to pop up everywhere. But which natural products are actually being tested in the lab and in clinical trials, and what’s the evidence for their effectiveness? Saraswati Sukumar, Ph.D., Johns Hopkins oncology(...)

What is PSA?

Posted by  | Prevention/Screening

“PSA, or prostate specific antigen, is an enzyme that normally appears in the ejaculate or central reproduction but when there’s a cancer present, it leaks into the circulation system so you can detect it in the bloodstream, where it becomes a marker of prostate cancer and other prostate diseases,” explains William G. Nelson, M.D., Ph.D.,(...)

Top Power Foods to Eat on Meatless Monday

Top Power Foods to Eat on Meatless Monday

Posted by  | Prevention/Screening

If the phrase “Meatless Monday” has you staring blankly into your fridge, take heart. There may already be a few “power foods” lurking in there that can help you get your week off to a healthy start, says nutritionist Lynda McIntytre. Avocado, beans, berries, broccoli, eggs, leeks, nuts, oats, spinach and yogurt make the top(...)

Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Posted by  | Issues & Perspectives

Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30 years of basic research at Johns Hopkins and its Bloomberg~Kimmel Institute, pembroluzimab now can be used for colon, pancreatic, stomach, ovarian and other cancers if genetic testing reveals defects in(...)

Lung cancer immunotherapy options expand

Lung cancer immunotherapy options expand

Posted by  | Issues & Perspectives

Patients and doctors received news this week of the FDA’s approval of the immunotherapy drug pembrolizumab in combination with platinum doublet chemotherapy as first-line therapy for all patients with non-small cell lung cancer, irrespective of patients’ tumor PD-L1 status. The new approval follows the FDA’s decision last November to approve pembrolizumab as a first-line therapy for some(...)

The State of the Bladder Cancer Battle

The State of the Bladder Cancer Battle

Posted by  | Patient Stories

On a weekend before a business trip, Ken Brothers noticed some blood in his urine. He wondered if it was related his recent loss of 40 pounds on a medically-supervised diet and emailed his doctor about it. Blood in the urine is a common symptom of bladder cancer, but its presence is not always associated(...)

Is there any test for prostate cancer that doesn’t depend on a blood test for PSA?

Posted by  | Prevention/Screening

“There are an increasing collection of tests that sample other aspects of prostate cancer in urine, blood or tissue, including acquired gene defects in the disease and acquired changes that cancers display that normal cells don’t,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. “I would(...)